SPDR S&P Biotech ETF
125 hedge funds and large institutions have $1.05B invested in SPDR S&P Biotech ETF in 2013 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 49 increasing their positions, 36 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
0% more capital invested
Capital invested by funds: $1.05B → $1.05B (+$2.37M)
14% less call options, than puts
Call options by funds: $15.5M | Put options by funds: $18M
76.23% less ownership
Funds ownership: 364.4% → 288.16% (-76%)
Holders
125
Holding in Top 10
5
Calls
$15.5M
Puts
$18M
Top Buyers
| 1 | +$32.5M | |
| 2 | +$12.9M | |
| 3 | +$12.3M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$9.13M |
| 5 |
LPL Financial
San Diego,
California
|
+$7.77M |
Top Sellers
| 1 | -$206M | |
| 2 | -$70.6M | |
| 3 | -$22.1M | |
| 4 |
IG
ING Group
Amsterdam,
Netherlands
|
-$17.5M |
| 5 |
HF
Hoxton Financial
Shepherdstown,
West Virginia
|
-$7.57M |